Literature DB >> 29090356

ILM peeling in nontractional diabetic macular edema: review and metanalysis.

M Rinaldi1, R dell'Omo2, F Morescalchi3, F Semeraro3, E Gambicorti3, F Cacciatore4,5, F Chiosi6, C Costagliola2.   

Abstract

PURPOSE: To evaluate the effect of internal limiting membrane (ILM) peeling during vitrectomy for nontractional diabetic macular edema.
METHODS: PUBMED, MEDLINE and CENTRAL were reviewed using the following terms (or combination of terms): diabetic macular edema, nontractional diabetic macular edema, internal limiting membrane peeling, vitrectomy, Müller cells. Randomized and nonrandomized studies were included. The eligible studies compared anatomical and functional outcomes of vitrectomy with or without ILM peeling for tractional and nontractional diabetic macular edema. Postoperative best-corrected visual acuity and central macular thickness were considered, respectively, the primary and secondary outcomes. Meta-analysis on mean differences between vitrectomy with and without ILM peeling was performed using inverse variance method in random effects.
RESULTS: Four studies with 672 patients were eligible for analysis. No significant difference was found between postoperative best-corrected visual acuity or best-corrected visual acuity change of ILM peeling group compared with nonpeeling group. There was no significant difference in postoperative central macular thickness and central macular thickness reduction between the two groups.
CONCLUSIONS: The visual acuity outcomes in patients affected by nontractional diabetic macular edema using pars plana vitrectomy with ILM peeling versus no ILM peeling were not significantly different. A larger prospective and randomized study would be necessary.

Entities:  

Keywords:  Diabetic macular edema; Diabetic retinopathy; Internal limiting membrane peeling; Meta-analysis; Müller cells; Vitrectomy

Mesh:

Year:  2017        PMID: 29090356     DOI: 10.1007/s10792-017-0761-6

Source DB:  PubMed          Journal:  Int Ophthalmol        ISSN: 0165-5701            Impact factor:   2.031


  32 in total

1.  VITRECTOMY WITH INTERNAL LIMITING MEMBRANE PEELING FOR TRACTIONAL AND NONTRACTIONAL DIABETIC MACULAR EDEMA: Long-term Results of a Comparative Study.

Authors:  Sophie Bonnin; Otman Sandali; Sébastien Bonnel; Claire Monin; Mohamed El Sanharawi
Journal:  Retina       Date:  2015-05       Impact factor: 4.256

2.  Change in Diabetic Retinopathy Through 2 Years: Secondary Analysis of a Randomized Clinical Trial Comparing Aflibercept, Bevacizumab, and Ranibizumab.

Authors:  Susan B Bressler; Danni Liu; Adam R Glassman; Barbara A Blodi; Alessandro A Castellarin; Lee M Jampol; Paul L Kaufman; Michele Melia; Harinderjit Singh; John A Wells
Journal:  JAMA Ophthalmol       Date:  2017-06-01       Impact factor: 7.389

3.  Vitrectomy for cystoid macular oedema with attached posterior hyaloid membrane in patients with diabetes.

Authors:  T Ikeda; K Sato; T Katano; Y Hayashi
Journal:  Br J Ophthalmol       Date:  1999-01       Impact factor: 4.638

Review 4.  Fluocinolone Acetonide Intravitreal Implant 0.19 mg (ILUVIEN®): A Review in Diabetic Macular Edema.

Authors:  Yahiya Y Syed
Journal:  Drugs       Date:  2017-04       Impact factor: 9.546

5.  Operating characteristics of a rank correlation test for publication bias.

Authors:  C B Begg; M Mazumdar
Journal:  Biometrics       Date:  1994-12       Impact factor: 2.571

Review 6.  Pathophysiology and treatment of diabetic retinopathy.

Authors:  Francesco Bandello; Rosangela Lattanzio; Ilaria Zucchiatti; Claudia Del Turco
Journal:  Acta Diabetol       Date:  2013-01-01       Impact factor: 4.280

7.  Resolution of diabetic macular edema after surgical removal of the posterior hyaloid and the inner limiting membrane.

Authors:  A Gandorfer; E M Messmer; M W Ulbig; A Kampik
Journal:  Retina       Date:  2000       Impact factor: 4.256

8.  [Long-term prognosis of internal limiting membrane peeling for idiopathic epiretinal membrane].

Authors:  Takuya Hasegawa; Kazuyuki Emi; Toshihide Ikeda; Masaki Watanabe; Gen Takaoka
Journal:  Nippon Ganka Gakkai Zasshi       Date:  2004-03

9.  Macular pucker removal with and without internal limiting membrane peeling: pilot study.

Authors:  Donald W Park; Pravin U Dugel; Jennifer Garda; Jack O Sipperley; Allen Thach; Scott R Sneed; Jennifer Blaisdell
Journal:  Ophthalmology       Date:  2003-01       Impact factor: 12.079

10.  Alterations in basement membrane immunoreactivity of the diabetic retina in three diabetic mouse models.

Authors:  E Abari; N Kociok; U Hartmann; I Semkova; M Paulsson; A Lo; A M Joussen
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2012-12-21       Impact factor: 3.117

View more
  4 in total

Review 1.  Treatment of Diabetic Macular Edema.

Authors:  Eric J Kim; Weijie V Lin; Sean M Rodriguez; Ariel Chen; Asad Loya; Christina Y Weng
Journal:  Curr Diab Rep       Date:  2019-07-29       Impact factor: 4.810

2.  Inner limiting membrane peeling prevents secondary epiretinal membrane after vitrectomy for proliferative diabetic retinopathy.

Authors:  Rong-Han Wu; Ming-Na Xu; Ke Lin; Ming-Xue Ren; Han Wen; Ke-Mi Feng; Hong-Jia Zhou; Nived Moonasar; Zhong Lin
Journal:  Int J Ophthalmol       Date:  2022-09-18       Impact factor: 1.645

3.  Evaluation of TGF-Beta 2 and VEGFα Gene Expression Levels in Epiretinal Membranes and Internal Limiting Membranes in the Course of Retinal Detachments, Proliferative Diabetic Retinopathy, Macular Holes, and Idiopathic Epiretinal Membranes.

Authors:  Joanna Stafiej; Karolina Kaźmierczak; Katarzyna Linkowska; Paweł Żuchowski; Tomasz Grzybowski; Grażyna Malukiewicz
Journal:  J Ophthalmol       Date:  2018-04-23       Impact factor: 1.909

4.  Efficacy and mechanism of anti-vascular endothelial growth factor drugs for diabetic macular edema patients.

Authors:  Yun-Fei Li; Qian Ren; Chao-Hui Sun; Li Li; Hai-Dong Lian; Rui-Xue Sun; Xian Su; Hua Yu
Journal:  World J Diabetes       Date:  2022-07-15
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.